Akt1 and Akt2-IN-1

Modify Date: 2024-01-13 20:55:05

Akt1 and Akt2-IN-1 Structure
Akt1 and Akt2-IN-1 structure
Common Name Akt1 and Akt2-IN-1
CAS Number 893422-47-4 Molecular Weight 539.63000
Density 1.3±0.1 g/cm3 Boiling Point N/A
Molecular Formula C33H29N7O Melting Point N/A
MSDS N/A Flash Point N/A

 Use of Akt1 and Akt2-IN-1


Akt1 and Akt2-IN-1 is an allosteric inhibitor of Akt1 (IC50=3.5 nM) and Akt2 (IC50=42 nM), with potent and balanced activity.

 Names

Name 3-Phenyl-2-[4-({4-[3-(2-pyridinyl)-1H-1,2,4-triazol-5-yl]-1-piperidinyl}methyl)phenyl]-1,6-naphthyridin-5(6H)-one
Synonym More Synonyms

 Akt1 and Akt2-IN-1 Biological Activity

Description Akt1 and Akt2-IN-1 is an allosteric inhibitor of Akt1 (IC50=3.5 nM) and Akt2 (IC50=42 nM), with potent and balanced activity.
Related Catalog
Target

Akt1:3.5 nM (IC50)

Akt2:42 nM (IC50)

In Vitro Consistent with the allosteric mode of inhibition, Akt1 and Akt2-IN-1 (Compound 17) is dependent on the PH-domain for Akt inhibition, is selective for Akt1/2 over Akt3 (IC50=1900 nM), and is highly selective over other members of the AGC family of kinases (>50 μM vs PKA, PKC, SGK). Akt1 and Akt2-IN-1 (Compound 17) has moderate activity in an hERG binding assay (IC50=5610 nM) and is a substrate for human P-glycoprotein[1].
In Vivo Akt1 and Akt2-IN-1 (Compound 17) is well tolerated in at exposures that provide high levels of Akt1 and 2 inhibition in vivo. Akt1 and Akt2-IN-1 (Compound 17) has also been shown to inhibit the growth of A2780 tumors in vivo when used as monotherapy. Akt1 and Akt2-IN-1 (Compound 17) has potent inhibitory activity against Akt1 and 2 in vivo in a mouse lung and efficacy in a tumor xenograft model. Akt1 and Akt2-IN-1 (Compound 17) shows good pharmacokinetics in rat with a low clearance of 4.6 mL/min/kg and a half-life of 3.8 h. Due to the improved cell potency, physical properties, and rodent pharmacokinetics of Akt1 and Akt2-IN-1 (Compound 17), tolerability and Akt inhibition are assessed in mice. Using an acute dosing schedule (IP dosing of 50 mg/kg at times 0, 3, and 8 h), administration of Akt1 and Akt2-IN-1 (Compound 17) is well tolerated in mice and shows high levels of Akt inhibition in mouse lung[1].
References

[1]. Bilodeau MT, Allosteric inhibitors of Akt1 and Akt2: a naphthyridinone with efficacy in an A2780 tumor xenograft model. Bioorg Med Chem Lett. 2008 Jun 1;18(11):3178-82.

 Chemical & Physical Properties

Density 1.3±0.1 g/cm3
Molecular Formula C33H29N7O
Molecular Weight 539.63000
Exact Mass 539.24300
PSA 103.45000
LogP 3.59
Index of Refraction 1.666
Storage condition 2-8℃

 Synonyms

1,6-Naphthyridin-5(6H)-one, 3-phenyl-2-[4-[[4-[3-(2-pyridinyl)-1H-1,2,4-triazol-5-yl]-1-piperidinyl]methyl]phenyl]-
3-Phenyl-2-[4-({4-[3-(2-pyridinyl)-1H-1,2,4-triazol-5-yl]-1-piperidinyl}methyl)phenyl]-1,6-naphthyridin-5(6H)-one
Akt1 and Akt2-IN-1
Top Suppliers:I want be here




Get all suppliers and price by the below link:

Akt1 and Akt2-IN-1 suppliers


Price: $499/10mM*1mLinDMSO

Reference only. check more Akt1 and Akt2-IN-1 price